alzheimer-s

Documents about alzheimer-s

• Cost-effectiveness of testing biofluid biomarkers to diagnose Alzheimer's disease: a systematic review.#440871NCBI PubMed Central
• Discovery of Anti-Neuroinflammatory Compounds in Alzheimer's Disease: Current Trends and Future Perspectives.#442856NCBI PubMed Central
• Lithium and the Brain-Bone Axis: A Bridge between Osteoporosis and Alzheimer's Disease.#442867NCBI PubMed Central
• Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer's disease.#449803NCBI PubMed Central
• Toward precision neuroscience in Alzheimer's disease: the role of multimodal AI.#455401NCBI PubMed Central
• Staging and Pseudotime Inference of Alzheimer's Disease Progression using Multimodal Imaging Data.#465092NCBI PubMed Central
• Advancing a systems-level understanding of neurodegeneration: the BrightFocus Alzheimer's disease research portfolio.#479189NCBI PubMed Central
• Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell-specific extracellular vesicles.#480744NCBI PubMed Central
• Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025).#28212NCBI PubMed Central
• Benzbromarone as a Novel Candidate for Preventing Alzheimer's Disease: Evidence From Real-World Data Screening and in Vitro Validation.#305025NCBI PubMed Central
• Handwriting as a Biomarker for Early Detection of Parkinson’s and Alzheimer’s Diseases: A Comprehensive Guide for Researchers.#364622NCBI PubMed Central
• Effects of mindfulness-based exercise on Parkinson's disease and Alzheimer's disease: a systematic review and meta-analysis.#455065NCBI PubMed Central
• Mortality of People With Alzheimer's Disease and Psychiatric Morbidity: A Nationwide Finnish Cohort Study.#602NCBI PubMed Central
• Sex differences in Alzheimer's disease: a systematic review of two decades of neuroimaging research.#4281NCBI PubMed Central
• Design of a configurable SoC for Alzheimer's disease detection based on multimodal signals.#25824NCBI PubMed Central
• Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trials.#125279NCBI PubMed Central
• The concurrent burden of Alzheimer's pathology, cerebral amyloid angiopathy, and microinfarcts on cognitive decline.#125414NCBI PubMed Central
• Lifestyle shapes preclinical social and microglial deficits in an Alzheimer's disease mouse model#125776Europe PMC
• Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease.#140481NCBI PubMed Central
• SRSF1 as a promising biomarker and key player in the pathogenesis of Alzheimer's disease.#143117NCBI PubMed Central
• Population-Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study.#146035NCBI PubMed Central
• Presymptomatic plasma biomarkers in autosomal dominant Alzheimer’s disease: sequence and timing#147926Unpaywall
• Kaempferol Improves Alzheimer's Disease by Inhibiting Neuronal Ferroptosis via Activating GPX4/AKR1C3 Signaling Pathway.#149934NCBI PubMed Central
• The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research.#157888NCBI PubMed Central
• Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease#159167PMC Full-Text (OAI)
• What can artificial intelligence bring to Alzheimer’s disease clinical trials? A first perspective#161340HAL (France)
• Caring for a partner with Alzheimer's disease: Intimacy, loss and the life that is possible#176200Bournemouth University Research Online (BURO)
• Corneal Immune Cell Alterations and Tau Pathology in a Mouse Model of Alzheimer's Disease.#193345NCBI PubMed Central
• Blind Identification of Altered Functional Subnetworks in Alzheimer’s Disease Using Resting-State fMRI.#196064NCBI PubMed Central
• A Balancing Act: Amyloid-β, Tau, and Excitation-Inhibition in Alzheimer's Disease#202223Europe PMC
• Bayesian value-of-infomation analysis: an application to a policy model of Alzheimer's disease#203904White Rose Research Online
• Bayesian value-of-infomation analysis: an application to a policy model of Alzheimer's disease#203944White Rose Research Online
• MC-RVAE: Multi-channel recurrent variational autoencoder for multimodal Alzheimer’s disease progression modelling#218002HAL (France)
• Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's disease.#218808NCBI PubMed Central
• Predictive Analysis of Brain-Derived Neurotrophic Factor and Apolipoprotein E SNPs in Alzheimer's Pathogenesis.#220822NCBI PubMed Central
• A paradigm of the diagnosis and treatment for the whole process of Alzheimer's disease.#220841NCBI PubMed Central
• Systems genetic dissection of brain gene expression reveals excitotoxic mechanisms of Alzheimer's disease#224187Europe PMC
• Cognitive reserve and gamma entrainment-related network changes in prodromal Alzheimer's disease#234347bioRxiv / medRxiv
• Oxidative stress biomarkers and flavonoids in Alzheimer's disease: current clinical evidence and therapeutic perspectives.#235963NCBI PubMed Central
• MRI-to-PET synthesis via deep learning for amyloid-β quantification in Alzheimer's disease.#236101NCBI PubMed Central
• Longitudinal Sparse Single-Omics Factor Analysis for High-Dimensional Blood Biomarkers in Alzheimer's Disease.#244168NCBI PubMed Central
• Artificial intelligence techniques for classification of Alzheimer's disease using neuroimaging data: a review.#251324NCBI PubMed Central
• Decision Strategies in AI-Based Ensemble Models in Opportunistic Alzheimer's Detection from Structural MRI.#258088NCBI PubMed Central
• Gene-Modulated Network Diffusion for Improved Modeling of Amyloid-β Spread in Alzheimer's Disease#261160bioRxiv / medRxiv
• The myth of digital biomarkers in Alzheimer's disease: how to make them a reality.#262889NCBI PubMed Central
• A dynamic risk prediction framework for Alzheimer's disease and related dementias with interpretability.#275498NCBI PubMed Central
• Use of Artificial Intelligence for the Early Detection and Prediction of Alzheimer’s Disease.#288954NCBI PubMed Central
• Treatments for Alzheimer’s and the declaration of Helsinki#291783HAL (France)
• Neurotransmitter-based machine-learning model for distinguishing Alzheimer's disease and mild cognitive impairment.#305350NCBI PubMed Central
• mTORC2-Na(v)1.2 signaling drives early hyperexcitability in Alzheimer's disease mouse model.#308737NCBI PubMed Central